Real-time three-dimensional fetal echocardiography using matrix probe

Acar, Philippe; Dulac, Yves; Taktak, A; Abadir, Sylvia

doi:10.1002/pd.1159

Cited by 49 publications

(41 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Current technology allows either biplane imaging (the display of 2 simultaneous planes without the need for moving the transducer) 268 or a rendered real-time display of any portion(s) of the pyramidal volume data set. 269,270 Several small postnatal studies have shown the superiority of real-time 3D/4D imaging compared with conventional 2D ultrasound in the evaluation of CHD, 272,272 but there have been no such comparison studies in fetuses with CHD. Currently available systems are limited by the size of the acquired volume, often too small for a complete evaluation of the fetal heart and great vessels.…”

Section: Acquisitionmentioning

confidence: 99%

Diagnosis and Treatment of Fetal Cardiac Disease

Donofrio¹,

Moon-Grady²,

Hornberger³

et al. 2014

Circulation

1,018

543

View full text Add to dashboard Cite

Background— The goal of this statement is to review available literature and to put forth a scientific statement on the current practice of fetal cardiac medicine, including the diagnosis and management of fetal cardiovascular disease. Methods and Results— A writing group appointed by the American Heart Association reviewed the available literature pertaining to topics relevant to fetal cardiac medicine, including the diagnosis of congenital heart disease and arrhythmias, assessment of cardiac function and the cardiovascular system, and available treatment options. The American College of Cardiology/American Heart Association classification of recommendations and level of evidence for practice guidelines were applied to the current practice of fetal cardiac medicine. Recommendations relating to the specifics of fetal diagnosis, including the timing of referral for study, indications for referral, and experience suggested for performance and interpretation of studies, are presented. The components of a fetal echocardiogram are described in detail, including descriptions of the assessment of cardiac anatomy, cardiac function, and rhythm. Complementary modalities for fetal cardiac assessment are reviewed, including the use of advanced ultrasound techniques, fetal magnetic resonance imaging, and fetal magnetocardiography and electrocardiography for rhythm assessment. Models for parental counseling and a discussion of parental stress and depression assessments are reviewed. Available fetal therapies, including medical management for arrhythmias or heart failure and closed or open intervention for diseases affecting the cardiovascular system such as twin–twin transfusion syndrome, lung masses, and vascular tumors, are highlighted. Catheter-based intervention strategies to prevent the progression of disease in utero are also discussed. Recommendations for delivery planning strategies for fetuses with congenital heart disease including models based on classification of disease severity and delivery room treatment will be highlighted. Outcome assessment is reviewed to show the benefit of prenatal diagnosis and management as they affect outcome for babies with congenital heart disease. Conclusions— Fetal cardiac medicine has evolved considerably over the past 2 decades, predominantly in response to advances in imaging technology and innovations in therapies. The diagnosis of cardiac disease in the fetus is mostly made with ultrasound; however, new technologies, including 3- and 4-dimensional echocardiography, magnetic resonance imaging, and fetal electrocardiography and magnetocardiography, are available. Medical and interventional treatments for select diseases and strategies for delivery room care enable stabilization of high-risk fetuses and contribute to improved outcomes. This statement highlights what is currently known and recommended on the basis of evidence and experience in the rapidly advancing and highly specialized field of fetal cardiac care.

show abstract

Section: Acquisitionmentioning

confidence: 99%

Diagnosis and Treatment of Fetal Cardiac Disease

Donofrio¹,

Moon-Grady²,

Hornberger³

et al. 2014

Circulation

1,018

543

View full text Add to dashboard Cite

show abstract

“…The additional image next to the regular image presents a cross-sectional plane or a parallel plane, making it possible to demonstrate any angle by rolling the track ball without tilting the probe. In clinical practice, this technique can reduce the operator's time for image acquisition by echocardiography, [96][97][98] and the same benefit can be expected in the abdominal field. Tracking the needle tip during percutaneous needle advancement under USguidance may be an additional application of this technique.…”

Section: Clinical Applications Of Contrast-enhanced Usmentioning

confidence: 84%

Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma

Maruyama

Ebara

2006

Int J Clin Oncol

View full text Add to dashboard Cite

Ultrasound (US) has the advantages of real-time observation, simple technique, and a noninvasive procedure compared to other imaging modalities. The recent development of digital technologies has enabled the observation of sonograms with improved signal-to-noise ratio, penetration, and spatial and contrast resolutions. Furthermore, microbubble contrast agents have increased the diagnostic ability of US examination, and the use of three-dimensional sonograms is now not unusual. These advances have furthered the usefulness of US for liver tumors in clinical practice. This article reviews the recent applications of US in the diagnosis and treatment of hepatocellular carcinoma.

show abstract

“…Gonçalves et al (2005b) established the clinical usefulness of STIC 4-D data sets and addressed the necessity for appropriate training in a study evaluating the agreement between two independent observers and the reproducibility of STIC technique to display standard cardiac views of the left and right ventricular outflow tracts by analyzing 20 volume data sets of satisfactory quality. Acar et al (2005) studied 60 fetuses between 22 and 34 wk of gestation using a matrix-array transducer based on both Biplane and Live 3-D imaging. In 16 fetuses, the fetal heart had morphologic abnormalities (hypoplastic left ventricle in 4, tetralogy of Fallot in 2, Ebstein anomaly in 2, rhabdomyomas in 2, hypoplastic right ventricle in 1) or myocardial dysfunction (5 fetuses).…”

Section: -Dus and Fetal Echocardiogrammentioning

confidence: 99%